# Editora Sanar

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/editora-sanar

- Industry: Education/Training
- Headquarters: Salvador, Brazil
- Website: www.sanarsaude.com
- Total disclosed funding: $11M
- Latest round: Series B (Apr 15, 2020)
- Investors on record: 4

## About

Editora Sanar SA is a Brazilian company focused on producing and distributing educational resources in the medical and health sectors, catering to students and professionals across various disciplines.Founded in 2014, Editora Sanar SA operates from Salvador, Brazil, specializing in educational publications for the health sciences. The company has successfully raised BRL 60 million in a Series B funding round on April 15, 2020, co-led by DNA Capital and Valor Capital Group, with additional investment from Vox Capital and e.Bricks Ventures. The company has completed a total of 2 deals to date.Sanar Saúde specializes in the publication and distribution of educational materials focused on various fields within the medical and health sectors. Their primary offerings include a wide range of textbooks, study guides, and supplementary resources tailored for students and professionals in disciplines such as Medicine, Nursing, Physiotherapy, Nutrition, Psychology, Pharmacy, Veterinary Medicine, Dentistry, Public Health, and Biomedicine. These products are designed to facilitate learning through clear language and practical approaches, addressing the specific needs of users who are preparing for academic and professional examinations, including undergraduate courses and residency programs. Sanar Saúde serves a diverse clientele, including students, educators, and healthcare professionals primarily in Brazil, and may also extend its reach to other Latin American markets, emphasizing the importance of accessible medical education.Sanar Saúde generates revenue through the direct sale of its educational products, which are offered both individually and in bundled formats. Transactions typically occur through a direct-to-consumer model, allowing customers to purchase products online, often facilitated by promotional campaigns such as discounts for specific payment methods or free shipping on orders exceeding a certain threshold. The revenue structure is bolstered by special offerings, which include flagship products like the "Sanar Note" series and various combo packages that provide comprehensive study resources. These products are competitively priced, reflecting their value proposition as indispensable tools for academic success in the health sciences. The company’s pricing strategies are designed to enhance customer engagement while ensuring a stable revenue stream through repeat purchases from a loyal customer base.In April 2020, Editora Sanar SA raised BRL 60 million in a Series B funding round to support its growth initiatives. The company plans to launch new educational products specifically designed for emerging health disciplines, aiming to release these by late 2023. Additionally, Sanar Saúde intends to expand its market reach into other Latin American countries by 2025, enhancing educational access across the region. The recent funding will be utilized to develop these new products and facilitate the company's geographic expansion.

## Funding rounds

- Series B, Apr 15, 2020, $11M — Valor Capital Group, Vox Capital, Igah Ventures, DNA Capital
- Series A, Apr 6, 2018 — Vox Capital, Igah Ventures

## Investors

- Vox Capital (https://capitalatlas.ai/funds/vox-capital) — Series A, Series B
- Igah Ventures (https://capitalatlas.ai/funds/igah-ventures) — Series A, Series B
- Valor Capital Group (https://capitalatlas.ai/funds/valor-capital-group) — Series B
- DNA Capital — Series B